Ethnic minorities form smaller proportions of Randomised controlled trial cohorts compared to the general population. Efforts to recruit more ethnic minority patients should be made in North America and Europe and more sites in underserved regions would ensure findings are generalisable to diverse groups. This review assessed the global population enrolled in contemporary RCTs for novel therapies now routinely given for gynecological cancers, adding novel understanding of the global distribution of research sites.